Choroidal thickness in idiopathic subfoveal choroidal neovascularization.

To evaluate choroidal thickness in patients with idiopathic choroidal neovascularization.
The observational case series study included patients who were consecutively diagnosed with idiopathic unilateral choroidal neovascularization as demonstrated by ophthalmoscopy, fluorescein angiography and enhanced depth imaging optical coherence tomography (EDI-OCT). Using EDI-OCT, choroidal thickness was measured at the fovea and at locations in a distance of 500, 1,000 and 1,500 μm temporal and nasal to the fovea.
Mean subfoveal choroidal thickness was significantly (p = 0.002) thicker in the study group than in the control group (357 ± 99 vs. 316 ± 83 μm). In a parallel manner, the differences between the study group and the control group in choroidal thickness were significant for all other measurement points, except for the examination at 1,500 μm nasal to the fovea (p = 0.09). The results remained unchanged after adjusting for axial length and age.
Idiopathic unilateral choroidal neovascularization is associated with a thickening of the choroid.
AuthorsXu-Sheng Cao, Xiao-Yan Peng, Qi-Sheng You, Yong-Peng Zhang, Jost B Jonas
JournalOphthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde (Ophthalmologica) Vol. 231 Issue 4 Pg. 221-5 ( 2014) ISSN: 1423-0267 [Electronic] Switzerland
PMID24603209 (Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)
Copyright© 2014 S. Karger AG, Basel.
Chemical References
  • Coloring Agents
  • Indocyanine Green
  • Adolescent
  • Adult
  • Choroid (pathology)
  • Choroidal Neovascularization (complications, diagnosis)
  • Coloring Agents
  • Female
  • Fluorescein Angiography
  • Fovea Centralis
  • Humans
  • Indocyanine Green
  • Male
  • Middle Aged
  • Ophthalmoscopy
  • Organ Size
  • Prospective Studies
  • Tomography, Optical Coherence
  • Visual Acuity (physiology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: